BofA/Merrill Ups BIIB To Buy

Monica Gerson , Benzinga Staff Writer

April 12, 2011 6:48am Comments

Analysts at BofA/Merrill upgrade Biogen Idec Inc (NASDAQ: BIIB) from “neutral” to “buy.” The target price for BIIB has been raised from $71 to $89.

BIIB shares surged 7.18% to close at $78.55 yesterday.

Posted-In: Bofa/Merrill Upgrades Price Target Analyst Ratings

Need analyst data?
Click here to see licensing options.

Stock	Firm	Action	PT
SEDG	B of A Securities	Maintains	411.0
PTLO	Piper Sandler	Maintains	28.0
AOUT	Lake Street	Maintains	26.0
RAPT	Piper Sandler	Maintains	52.0
OCX	Lake Street	Maintains	6.0

1	NSC, UNP: Union Pacific Sticks To Annual Outlook, Confirms Merger Talks With Norfo...
2	AN, DLR: US Stocks Hit New Highs As Magnificent Seven Reach $19 Trillion:...
3	INTC: Intel Q2 Earnings: Revenue Beat, EPS Miss, Chipmaker Sees �...
4	$BTC, $ETH: Bitcoin Could See Bearish August, Analyst Says—Wh...
5	TSLA, CHTR: Dow Dips Over 300 Points Amid Alphabet, T...
6	GOOG, GOOGL: Google's AI Push Hits 2 B...
7	NEM: World's Largest Gold M...

1	BYND, TSN: US Can't Meet Its Own Beef Demand, Let Alone Export 'So Much&...
2	GEO, CXW: FEMA Commits $608 Million To Support Trump's Migrant Deten...
3	META: OpenAI Chairman Says Only Tech Giants Can Afford New AI Mod...
4	META: Mark Zuckerberg Names OpenAI Veteran Shengjia Zhao As C...
5	NASA Confirms Major Workforce Reduction: 1 in 5 Employe...
6	CLF: Insider Trading Concerns Swirl Around Rep. Mike Kell...
7	TSLA: Elon Musk's Tesla To Include Shareholder Pr...

Market Overview